000130347 001__ 130347
000130347 005__ 20240228143426.0
000130347 0247_ $$2doi$$a10.1002/path.4800
000130347 0247_ $$2pmid$$apmid:27569598
000130347 0247_ $$2ISSN$$a0022-3417
000130347 0247_ $$2ISSN$$a0368-3494
000130347 0247_ $$2ISSN$$a1096-9896
000130347 0247_ $$2altmetric$$aaltmetric:10904266
000130347 037__ $$aDKFZ-2017-05426
000130347 041__ $$aeng
000130347 082__ $$a610
000130347 1001_ $$0P:(DE-He78)e9c55f46b4b06cf835834ee7e3e00db8$$aPoschke, Isabel$$b0$$eFirst author$$udkfz
000130347 245__ $$aNext-generation TCR sequencing - a tool to understand T-cell infiltration in human cancers.
000130347 260__ $$aBognor Regis [u.a.]$$bWiley$$c2016
000130347 3367_ $$2DRIVER$$aarticle
000130347 3367_ $$2DataCite$$aOutput Types/Journal article
000130347 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1524815673_6737
000130347 3367_ $$2BibTeX$$aARTICLE
000130347 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000130347 3367_ $$00$$2EndNote$$aJournal Article
000130347 520__ $$aTumour-infiltrating lymphocytes (TILs) are known to mediate potent anti-tumour activity. As T-cell-based therapies start to reach clinical practice, it becomes increasingly important to understand what characterizes a successful anti-tumour T-cell response and to exploit this knowledge for patient stratification. Next-generation sequencing of T-cell receptors (TCRs) promises to provide insights into the complexity of the tumour T-cell infiltrate that go beyond the phenotypic level. A recent study by Chen et al made use of this novel technology to demonstrate that the TIL repertoire of oesophageal squamous cell carcinoma patients is distinct from that of non-tumour sites and is characterized by significant intratumoural heterogeneity. This study illustrates the great potential of the method and addresses several technical and biological hurdles that need to be considered. Careful sampling, normalization, and error correction will be required to optimally use TCR sequencing to answer biological questions and define predictive biomarkers, e.g. for cancer immunotherapy. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
000130347 536__ $$0G:(DE-HGF)POF3-317$$a317 - Translational cancer research (POF3-317)$$cPOF3-317$$fPOF III$$x0
000130347 588__ $$aDataset connected to CrossRef, PubMed,
000130347 7001_ $$0P:(DE-He78)fd2afb52af9b43e5bb535b58dfed2e33$$aFlossdorf, Michael$$b1$$udkfz
000130347 7001_ $$0P:(DE-He78)81ae96953d6149e4307057d71a190019$$aOffringa, Rienk$$b2$$eLast author$$udkfz
000130347 773__ $$0PERI:(DE-600)1475280-3$$a10.1002/path.4800$$gVol. 240, no. 4, p. 384 - 386$$n4$$p384 - 386$$tThe journal of pathology$$v240$$x0022-3417$$y2016
000130347 909CO $$ooai:inrepo02.dkfz.de:130347$$pVDB
000130347 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e9c55f46b4b06cf835834ee7e3e00db8$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000130347 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)fd2afb52af9b43e5bb535b58dfed2e33$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000130347 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)81ae96953d6149e4307057d71a190019$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000130347 9131_ $$0G:(DE-HGF)POF3-317$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTranslational cancer research$$x0
000130347 9141_ $$y2016
000130347 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000130347 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000130347 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000130347 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000130347 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ PATHOL : 2015
000130347 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000130347 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000130347 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000130347 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000130347 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000130347 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000130347 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000130347 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bJ PATHOL : 2015
000130347 9201_ $$0I:(DE-He78)G180-20160331$$kG180$$lMolekulare Grundlagen Gastrointestinaler Tumoren$$x0
000130347 980__ $$ajournal
000130347 980__ $$aVDB
000130347 980__ $$aI:(DE-He78)G180-20160331
000130347 980__ $$aUNRESTRICTED